JACC: Cardiooncology

Papers
(The H4-Index of JACC: Cardiooncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board148
Full Issue PDF136
Full Issue PDF118
Full Issue PDF114
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque113
Priorities in Cardio-Oncology97
Cardiovascular Safety in Oncology Clinical Trials92
Hormonal Therapy and Cardiovascular Health86
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients71
Full Issue PDF65
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy63
Atrial Fibrillation in Patients With Cancer62
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part61
Epigenomics of Cardio-Oncology60
Balancing Promise and Evidence58
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy57
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes56
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies55
Full Issue PDF54
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD53
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy51
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors50
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients48
Cardiac Risk Stratification Before Lung Cancer Radiation48
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy47
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms46
Frailty44
CARDIAC, MUSCULAR, AND NEUROLOGICAL TOXICITY SECONDARY TO PEMBROLIZUMAB IN A PATIENT WITH MELANOMA44
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma42
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis39
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis39
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)37
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients36
PROPORTIONATE AND ABSOLUTE PULMONARY EMBOLISM MORTALITY IN ONCOLOGY IN THE UNITED STATES FROM 1999-201936
Editorial Board/Officers Page34
Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer34
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD34
Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer34
0.20973992347717